Clinical Study Evaluating the Proper Surgical Safety Margin for Early Stage Oral Tongue Cancers
NCT04738786 · Status: TERMINATED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 125
Last updated 2025-05-18
Summary
A prospective multicenter randomized non-inferiority clinical trial, to evaluate the efficacy and safety of 1.0 cm-safety margin surgery, compared with 1.5 cm safety margin surgery for cT1-2N0 oral tongue cancer
Summary:
A current standard primary treatment for oral tongue cancer is a curative surgical resection with/without adjuvant radiation treatments (or chemoradiation).
In pathological analysis of surgical specimens, more than 5 mm of non-tumorous tissues from the tumor border is regarded as a safe negative resection margin, according to the NCCN guideline (the National Comprehensive Cancer Network, Dec 10. 2020). To achieve this clear margin, surgeons are apt to use a 1.0 to 1.5 cm safety margin around the gross tumor during surgery, considering 30-50% tumor shrinkage in tissue fixation process.
Many previous retrospective data have been reported to suggest the optimal or proper surgical extent for oral tongue cancer. Wider resection can lead to better local control, however, it sacrifices more normal tissue, resulting in the functional deficit of tongue (speech and swallowing), even with reconstruction.
Unfortunately up to now, no prospective comparison of a different surgical safety margin for oral tongue cancer have been conducted to draw a more solid conclusion. Particularly in early stage oral tongue cancer (cT1-2N0), some study results have suggested that less than 5 mm resection margin in pathology specimens can be also safe and effective in terms of tumor control.
To achieve a well-grounded result about the proper surgical safety margin in early stage (cT1-2N0) oral tongue cancer, we will compare the outcomes of the two (1.5 cm versus 1.0 cm) surgical safety margin in curative resection for cT1-2N0 oral tongue cancer.
Conditions
- Tongue Cancer
- Tongue Cancer TNM Staging Primary Tumor (T) T1
- Tongue Cancer TNM Staging Primary Tumor (T) T2
- Surgery
- Resection Margin
- Squamous Cell Carcinoma
Interventions
- PROCEDURE
-
1.5 cm surgical safety margin for cT1-2N0 oral tongue cancers
Surgical resection including 1.5 cm normal tissue around the gross tumors Definition of safety margin: A surgical safety margin is defined as the margin of apparently non-tumorous tissue around a tumor that has been surgically removed (Resected normal-looking tissues from the gross tumor border). The surgical safety margin is applied to all directions of 3-dimensional tumors (mucosal and deep side).
- PROCEDURE
-
1.0 cm surgical safety margin for cT1-2N0 oral tongue cancers
Surgical resection including 1.0 cm normal tissue around the gross tumors
Sponsors & Collaborators
-
Seoul National University Hospital
collaborator OTHER -
Asan Medical Center
collaborator OTHER -
Ajou University School of Medicine
collaborator OTHER -
National Cancer Center, Korea
collaborator OTHER_GOV -
Inje University
collaborator OTHER -
Seoul National University Bundang Hospital
collaborator OTHER -
Kangbuk Samsung Hospital
collaborator OTHER -
Dong-A University Hospital
collaborator OTHER -
Samsung Medical Center
lead OTHER
Principal Investigators
-
Han-Sin Jeong, MD PhD · Head and Neck Cancer Center, Samsung Medical Center, Korea
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- DOUBLE
- Model
- PARALLEL
Eligibility
- Min Age
- 20 Years
- Max Age
- 80 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2021-01-18
- Primary Completion
- 2025-01-31
- Completion
- 2025-01-31
Countries
- South Korea
Study Locations
More Related Trials
-
Speech-based AI-driven Diagnostics and Rehabilitation for Oral and Oropharyngeal Cancer.
NCT07347899 ·Status: COMPLETED
-
The Effect of Environmental Factors on Gastric Cancer Based on Macrogenome
NCT06854146 ·Status: ACTIVE_NOT_RECRUITING
-
Establishment of Tongue Image Database and Machine Learning Model for Malignant Tumors Diagnosis
NCT04793672 ·Status: COMPLETED
-
Comparison of Genomic and Transcriptomic Patterns Between CTC and Metastatic Tumormetastatic Tumor
NCT04932343 ·Status: UNKNOWN
-
A Multi-center, Retrospective Analysis of Clinical Character, Outcome and Prognosis of Lymphoepithelioma-like Carcinoma
NCT04614818 ·Status: UNKNOWN
-
Study of Biomarker From Blood and Tissue of Head and Neck Carcinoma
NCT01171235 ·Status: UNKNOWN
-
Feasibility of Intratumoral Washing Fluid for Detecting EGFR Mutations in Lung Cancer
NCT05517083 ·Status: COMPLETED ·Phase: NA
-
Study of the Relationship Between Clinical, Imaging and Biological Data in Patients With Squamous Cell Carcinoma of the Tongue
NCT06450080 ·Status: RECRUITING ·Phase: NA
-
Transthoracic vs Transbronchial Radiofrequency Ablation for Lung Cancer
NCT06503744 ·Status: RECRUITING ·Phase: NA
-
Liquid Biopsy-Based Novel Modality for Postoperative Management of Lung Cancer
NCT06930807 ·Status: RECRUITING ·Phase: NA
-
Prospective Study for Molecular Biomarkers of Normal Nasopharyngeal Tissue
NCT03048305 ·Status: UNKNOWN
-
Effect of Nurse-Led Individualized Follow-Up Intervention on Patients With Nasopharyngeal Carcinoma
NCT06572293 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Liquid Biopsy in Advanced Oligometastatic NSCLC Receiving Surgery
NCT05648370 ·Status: UNKNOWN
-
Development of a Machine Learning Model for Nasopharyngeal Carcinoma Screening Based on Tongue Imaging
NCT06129201 ·Status: NOT_YET_RECRUITING
-
Analysis of the Incidence of Expression of Tumor Antigens in Pathologically Proven Stage I, II and III Non-Small Cell Lung Cancer(NSCLC) in Asiatic Patients
NCT01837511 ·Status: COMPLETED
-
To Develop and Validate a Nasoendoscopic Intelligent Diagnostic System for Nasopharyngeal Carcinoma
NCT04547673 ·Status: RECRUITING
-
Efficacy and Safety of Microwave Ablation Combined With Camrelizumab and Chemotherapy in Patients With Advanced Non-small Cell Lung Cancer: a Multicenter, Open, Prospective Study
NCT05532527 ·Status: UNKNOWN ·Phase: NA
-
Diagnostic Trial in Patients Who Are Undergoing Surgery for Early Stage Mouth Cancer
NCT00042926 ·Status: COMPLETED ·Phase: NA
-
Transthoracic vs Transbronchial Cryoablation for Early-stage Peripheral Lung Cancer
NCT06572540 ·Status: RECRUITING ·Phase: NA
-
Evaluation of Cyberknife Precision Radiation Delivery System for Unresectable Malignant Lung Cancer
NCT00238602 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
10-year Retrospective Study of Oral and Maxillofacial Squamous Cell Carcinoma
NCT06366906 ·Status: COMPLETED
-
Application of Carbon Dioxide for Identifying the Intersegmental Plane in Thoracoscopic Segmentectomy
NCT05350137 ·Status: COMPLETED ·Phase: NA
-
Comparison Between Wedge Resection and Segmentectomy for Ground Glass Opacity- Dominant Stage IA NSCLC
NCT02718365 ·Status: UNKNOWN ·Phase: NA
-
Pre-operative Chemotherapy Versus Concurrent Chemoradiotherapy in N2 Positive IIIA Non Small Cell Lung Cancer (NSCLC)
NCT00452803 ·Status: UNKNOWN ·Phase: PHASE2
-
Practical Usability of EGFR Mutation Detection in ctDNA From Resectable NSCLC
NCT04922073 ·Status: UNKNOWN